Human
Growth Hormone
'Overused' in Children
Excerpt
By
Richard Woodman,
Reuters
Health
LONDON (Reuters Health) - More than one in five children treated
with growth hormone in Britain are taking it for unlicenced reasons
and are unlikely to gain much extra height, the Drug and Therapeutics
Bulletin said on Thursday.
The bulletin, an independent review for doctors published by the
Consumers' Association, said that short stature was one of the most
common chronic problems in paediatric practice and might be regarded
as a disability by parents.
It pointed out, however, that synthetic human growth hormone
(somatropin) is only licenced for use in children with growth
hormone deficiency and children with short stature associated
with Turner's syndrome, chronically poor kidney function or Prader-Willi
syndrome.
It said that an estimated 22% of children receiving growth hormone
were receiving the therapy for unlicenced indications, where growth
hormone secretion was within normal levels, such as children with
short stature due to intra-uterine growth retardation or skeletal
dysplasia.
"While several small randomised controlled trials and observational
studies have suggested that some children with idiopathic short
stature do have a short-term increase in growth rate when given
growth hormone therapy, their overall mean final height gain over
predicted adult height is small--about 2.7 cm," according to the
report. "Idiopathic" means without known cause.
That compared with a gain of 25 cm to 30 cm in children with
growth hormone deficiency.
It was also unclear, the report stated, whether growth hormone
therapy in the unlicenced indications led to any improvement in
academic achievement, employment prospects, psychological health
or quality of life.
It concluded that the therapy should be given only for these
unlicenced uses as part of controlled clinical trials.
In England alone in 2000, the bulletin estimated that over 39,000
prescriptions, costing around £27 million, were dispensed for
synthetic human growth hormone.
SOURCE: Drug and Therapeutics Bulletin 2002;40:17-20.
Reference
Source 89
For more information on how to prevent other diseases, use
PreventDisease.com's "Quick
Prevention Resources".
|